gemcitabine has been researched along with EHS Tumor in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cappellacci, L; Franchetti, P; Grifantini, M; Petrelli, R; Vita, P | 1 |
Ang, KK; Buchmiller, L; Elshaikh, M; Hittelman, K; Hunter, NR; Kishi, K; Mason, KA; Milas, L | 1 |
Fujita, H; Okamoto, M | 1 |
3 other study(ies) available for gemcitabine and EHS Tumor
Article | Year |
---|---|
Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine.
Topics: Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Bromodeoxyuridine; Cell Line, Tumor; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Rats; Sarcoma, Experimental | 2008 |
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
Topics: Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Dose Fractionation, Radiation; Drug Administration Schedule; Gemcitabine; Intestinal Mucosa; Jejunum; Mice; Mice, Inbred C3H; Radiation-Sensitizing Agents; Sarcoma, Experimental; Specific Pathogen-Free Organisms | 1999 |
[Pharmacokinetic studies of dFdC (2',2'-difluorodeoxycytidine), ara-C and BH-AC (N4-behenoyl ara-C) in experimental animals].
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cytarabine; Deoxycytidine; Gemcitabine; Half-Life; Liver; Mice; Rabbits; Sarcoma, Experimental | 1992 |